Видео ютуба по тегу Azitra Inc

Azitra's (AZTR) COO Travis Whitfill Gives Outlook on ATR-12
Azitra's (AZTR) COO Travis Whitfill Gives Outlook on ATR-12
STOCK REVIEW - Azitra, Inc ($AZTR)
STOCK REVIEW - Azitra, Inc ($AZTR)
Azitra, Inc. (AZTR)
Azitra, Inc. (AZTR)
Azitra's Pipeline Summer 2025
Azitra's Pipeline Summer 2025
АКЦИИ AZTR: ВОЗМОЖНО ВОССТАНОВЛЕНИЕ? ($AZTR)
АКЦИИ AZTR: ВОЗМОЖНО ВОССТАНОВЛЕНИЕ? ($AZTR)
Azitra's (AZTR) COO Travis Whitfill Outlines What's Next for ATR-04
Azitra's (AZTR) COO Travis Whitfill Outlines What's Next for ATR-04
$AZTR - Azitra Inc. IPO May 18, 2023
$AZTR - Azitra Inc. IPO May 18, 2023
Chardan Leadership Call: Azitra (AZTR)
Chardan Leadership Call: Azitra (AZTR)
My Insight on AZITRA's NYSE American Tightrope
My Insight on AZITRA's NYSE American Tightrope
AZTR Stock MASSIVE NEWS! (Thank Me Later Bro.) Azitra
AZTR Stock MASSIVE NEWS! (Thank Me Later Bro.) Azitra
AZTR Stock - Azitra Inc Stock Breaking News Today | AZTR Stock Price | AZTR Stock Target
AZTR Stock - Azitra Inc Stock Breaking News Today | AZTR Stock Price | AZTR Stock Target
Анализ акций Azitra Inc (AZTR): падение акций, одобрение FDA и обновление новых предложений
Анализ акций Azitra Inc (AZTR): падение акций, одобрение FDA и обновление новых предложений
$AZTR Azitra Stock Analysis #aztr
$AZTR Azitra Stock Analysis #aztr
Azitra Stock: My Question After Reading This 8-K Report
Azitra Stock: My Question After Reading This 8-K Report
My Take: Azitra's Dilution Risk in Their Latest Raise
My Take: Azitra's Dilution Risk in Their Latest Raise
Catching up with Azitra’s Travis Whitfill | $AZTR
Catching up with Azitra’s Travis Whitfill | $AZTR
AZTR Stock Analysis (Azitra Stock) October 20, 2025
AZTR Stock Analysis (Azitra Stock) October 20, 2025
DON'T BUY Azitra Stock (Until You Watch This Analysis) #AZTR
DON'T BUY Azitra Stock (Until You Watch This Analysis) #AZTR
Engineering bacteria to treat skin disease – Azitra
Engineering bacteria to treat skin disease – Azitra
AZTR Stock: Doses First Patient in EGFR Inhibitor-Associated Skin Rash Study
AZTR Stock: Doses First Patient in EGFR Inhibitor-Associated Skin Rash Study